Texas State Representative
Travis Clardy 2015 - 84th Regular - Authored & Sponsored Legislation (Page 9)
Legislative Session
Sponsor of Legislation
TX
Texas 2015 - 84th Regular
Texas Senate Bill SB1066
Filed
Out of Senate Committee
Voted on by Senate
Out of House Committee
Voted on by House
Governor Action
Bill Becomes Law
Relating to continuing eligibility requirements for institutions of higher education to participate in the Texas Science, Technology, Engineering, and Mathematics (T-STEM) Challenge Scholarship Program.
TX
Texas 2015 - 84th Regular
Texas Senate Bill SB1267
Filed
Out of Senate Committee
Voted on by Senate
Out of House Committee
Voted on by House
Governor Action
Bill Becomes Law
Relating to contested cases conducted under the Administrative Procedure Act.
TX
Texas 2015 - 84th Regular
Texas Senate Bill SB1457
Filed
Out of Senate Committee
Voted on by Senate
Out of House Committee
Voted on by House
Governor Action
Bill Becomes Law
Relating to bad faith claims of patent infringement; providing a civil penalty.
TX
Texas 2015 - 84th Regular
Texas Senate Bill SB1466
Filed
Out of Senate Committee
Voted on by Senate
Out of House Committee
Voted on by House
Governor Action
Bill Becomes Law
Relating to the definition of medical schools for medical residency programs.
TX
Texas 2015 - 84th Regular
Texas Senate Bill SB172
Filed
11/10/14
Out of Senate Committee
Voted on by Senate
Out of House Committee
Voted on by House
Governor Action
Bill Becomes Law
Relating to the addition of certain substances to Penalty Groups 1-A and 2 of the Texas Controlled Substances Act for criminal prosecution and other purposes.
TX
Texas 2015 - 84th Regular
Texas Senate Bill SB173
Filed
11/10/14
Out of Senate Committee
Voted on by Senate
Out of House Committee
Voted on by House
Governor Action
Bill Becomes Law
Relating to the designation for criminal prosecution and other purposes of certain chemicals commonly referred to as synthetic cannabinoids as controlled substances and controlled substance analogues under the Texas Controlled Substances Act.
TX
Texas 2015 - 84th Regular
Texas Senate Bill SB453
Filed
Out of Senate Committee
Voted on by Senate
Out of House Committee
Voted on by House
Governor Action
Bill Becomes Law
Relating to minimum scores required for public school students to receive credit by an examination administered through the College-Level Examination Program.
TX
Texas 2015 - 84th Regular
Texas Senate Bill SB686
Filed
Out of Senate Committee
Voted on by Senate
Out of House Committee
Voted on by House
Governor Action
Bill Becomes Law
Relating to the Math and Science Scholars Loan Repayment Program.
TX
Texas 2015 - 84th Regular
Texas Senate Bill SB824
Filed
Out of Senate Committee
Voted on by Senate
Out of House Committee
Voted on by House
Governor Action
Bill Becomes Law
Relating to the number of jurors required in certain civil cases pending in a statutory county court.
Joint Sponsor of Legislation
TX
Texas 2015 - 84th Regular
Texas Senate Bill SB1587
Filed
Out of Senate Committee
Voted on by Senate
Out of House Committee
Voted on by House
Governor Action
Bill Becomes Law
Relating to the creation and operations of health care provider participation programs in certain counties.
TX
Texas 2015 - 84th Regular
Texas Senate Bill SB776
Filed
Out of Senate Committee
Voted on by Senate
Out of House Committee
Voted on by House
Governor Action
Bill Becomes Law
Relating to the operations of a municipally owned utility or municipal power agency; providing authority to issue bonds.
Co-Sponsor of Legislation
TX
Texas 2015 - 84th Regular
Texas Senate Bill SB2065
Filed
Out of Senate Committee
Voted on by Senate
Out of House Committee
Voted on by House
Governor Action
Bill Becomes Law
Relating to the rights of certain religious organizations and individuals relating to a marriage that violates a sincerely held religious belief.
TX
Texas 2015 - 84th Regular
Texas Senate Bill SB694
Filed
Out of Senate Committee
Voted on by Senate
Out of House Committee
Voted on by House
Governor Action
Bill Becomes Law
Relating to authorizing patients with certain terminal illnesses to access certain investigational drugs, biological products, and devices that are in clinical trials.